On behalf of the

CBSA Board of

Directors, I want to

thank all of our

BioWest speakers,

sponsors, exhibi-

tors and attendees.

We had a dynamic,

informative confer-

ence and have received positive feedback

from many of you. Over 350 attendees en-

joyed a full day including keynote presenta-

tions from Ginger Graham and Mike Huck-

man and the track sessions. The day ended

with the Venture Showcase presentations by

five local startup companies from the medi-

cal device, diagnostic and therapeutic areas.

VetDC from Ft Collins won the competition

and a cash prize of $7,500.

As we look ahead we have several other

major programs coming up including the An-

nual Awards Dinner on December 6th. I’m

pleased to share with you that we have con-

firmed George Sparks, President and CEO

of Denver Museum of Nature and Science

as our keynote speaker. Tickets and tables

are now available!

The state legislature will see significant

changes after the 2012 election with many

term limited seats available. The goal of

CBSA is to keep our industry front and cen-

ter to those running for election and re-

election. We have and will continue to host

a series of legislator briefings in key commu-

nities to inform and update state leaders on

the importance of our industry to Colorado

and introduce them to companies in their

community.

The CBSA staff is also preparing to attend

the AdvaMed Conference in Boston, MA in

October. We look forward to representing

Colorado’s 350 medical device and diagnos-

tic companies and promoting our industry at

a national level.

The search process for filling the President/

CEO position is well underway. Our ad hoc

search committee is currently reviewing ap-

plications and will start interviews shortly. I

look forward to keeping you up-to-date on

our progress.

Sincerely,

Steve Orndorff, Ph.D.

Board Chair,

Colorado BioScience Association

President/CEO, Ariel Pharmaceuticals

FOCUS

S E P T E M B E R

2 0 1 2

Inside this issue:

From the Board Chair 1

FRA Grand Opening 2

Internship Highlights 3

Upcoming Events 4

www.CoBioScience.com

Colorado BioScience Association | 216 16th Street, Suite 850 | Denver, CO 80202 | cbsainfo@CoBioScience.com | 303.592.4073

Letter from the Board Chair

2 w w w . C o B i o S c i e n c e . c o m

Accelerator Grand Opening

Fitzsimons Redevelopment Authority (FRA) officially

opened its new Accelerator Building August 22, 2012, ad-

jacent to its original Incubator Building at the Bioscience

Park Center (BCP) in the Fitzsimons Life Science District.

The four biotech companies — Mitomics USA, Isogenis/

Greffex, Touch of Life Technologies and Light Labs — are

among 39 firms that have been housed in Bioscience

Park Center. They have run out of room and are graduat-

ing to the $8 million, three-story, 37,000-square-foot ex-

pansion, taking up most of that space. The new facility

already is 78 percent leased.

"It's a nice problem to have when you haven't even

opened your new building yet and you could potentially

now be limited in space again," said the authority's new

president and CEO, Steve VanNurden to the Denver Post.

The new space includes:

Built-to-suit spaces with access to incubator services

and amenities

World class resources at your finger tips - university

research facilities and major medical centers

Collaborative environment with complimentary busi-

ness and networking opportunities

"The Bioscience Park Center is designed to foster a col-

laborative environment—by having established

companies in close proximity to incubator startups—

further promoting an essential atmosphere that makes the

Fitzsimons Life Science District an important hub in the

overall growth of Colorado’s bioscience industry," Van-

Nurden explains.

Welcome presentation (clockwise) Steve Hogan, Mayor of the City of

Aurora; John Shaw, FRA Board Chair; Steve VanNurden, President/CEO,

FRA

Second floor view of Accelerator lobby.

Street view of new Accelerator building.

3 w w w . C o B i o S c i e n c e . c o m

Internship Program Highlights

TOLMAR is a Fort Collins, Colorado based pharmaceuti-

cal research, development, manufacturing and commer-

cial operations company. TOLMAR develops and manu-

facturers both proprietary and generic pharmaceutical

products with specific focus in therapeutic areas of dental,

dermatology, and oncology.

TOLMAR is proud to offer a robust, paid summer intern-

ship program that provides challenging assignments for

students to expand their skills and contribute to important

projects impacting the company. This summer, TOLMAR

was host to nine interns with students representing a

spectrum of local schools including, Colorado State, Uni-

versity of Colorado, University of Northern Colorado, and

School of Mines. Students worked in a variety of depart-

ments across the company including, Process and Ana-

lytical Development, Engineering, Clinical, Microbiology

and Quality Control.

Carolyn Worley, University of Colorado Student ,

Analytical Development Department Intern

“Interning at TOLMAR in the Analytical Development de-

partment has afforded me the opportunity to engage in

method development from beginning to end. Focusing on

gas chromatography (GC), development on a new test

method begins by finding the optimal chromatographic

parameters, ones that would allow for good peak size,

shape and resolution. Here, problem solving and critical

thinking are employed to investigate how disparities in the

method parameters could effect the final chromatograms.

This internship has allowed me to take classroom

knowledge and apply it to practical applications. I am very

grateful to have been at TOLMAR this summer; the ac-

cepting and helpful nature of everyone I interacted with

coupled with the industry knowledge I gained provided an

exceptional experience.”

Carolyn Worley, University of Colorado Student ,

Analytical Development Department Intern

“Overall, our internship has offered numerous learning

opportunities and invaluable experience. Our internship at

TOLMAR has given us an increased understanding of the

pharmaceutical industry and the professional world in

general that compliments our academic education and

prepares us for life after graduation.”

Kyle Smith and Ashley Lavelle, Colorado State University Students,

Process Engineering Interns

CBSA Staff

April Giles

Executive Vice President

agiles@cobioscience.com

Tracey Nilson

Program Manager

tnilson@cobioscience.com

Mae Desaire

Director of Marketing

mdesaire@cobioscience.com

Steve Ambriz

Operations Manager

sambriz@cobioscience.com

www.facebook.com/ColoradoBioScienceAssociation

www.twitter.com/cobioscience

http://tinyurl.com/CBSALinkedInGroup

Upcoming Events

4 w w w . C o B i o S c i e n c e . c o m

Medical Device Networking

Oct 18

Patent Office Update

Oct 24

Innovation in Cell Culture: Cells, Media and Therapies

Nov 1

Colorado Life Science Night

Nov 13

Medical Device Symposium

Nov 14

Annual Awards Dinner

Dec 6

Annual Awards Dinner

Thursday, December 6, 2012

Denver Hyatt Convention Center

Colorado BioScience Association's annual celebration recognizing outstanding achievements in the Colorado life sciences industry and featuring keynote speaker George Sparks President & CEO of Denver Museum of Nature and Science.

Tickets and Tables are now on available

Individual Tickets: $150 each

Reserved Table for Eight:

$1,250 (member)/ $1,500 (non-member)